Open Label Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice
Sponsor study identifier
observational
2,000
1 country
1
Study Start
June 14, 2016
Actual (reported)Primary Completion
December 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of this research study is to evaluate the feasibility in conducting advanced MRI sequences in a clinical setting. The study will be observational in nature, and will only evaluate the studies of patients that have already been prescribed an advanced MRI for clinical neurological purposes. The only difference for the subject in participating in this study is that the data and information about their scan can be used and disclosed for research purposes, which is understanding if the time of the scan, patient comfort, and quality of the data are feasible. Standard MRI's have been extremely beneficial in the diagnosis and assessment of disease, injury, and anomalies throughout the body. Adding advanced MRI sequences to the arsenal of current standard MRI sequences, as well as analyzing the clinical significance of the data, may improve the benefits of MRI in the future. Within this scope, the study will be looking at the following factors:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 14, 2016
Actual (reported)June 12, 2017
Actual (reported)July 28, 2017
Actual (reported)December 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Number of subjects who successfully complete an fMRI scan
In order to assess scan feasibility, we will keep track of the total number of patients who sign the consent form and are able to complete the fMRI scan.
Through study completion, an average of 1 year
Subject appointment time vs. subject arrival time
Through study completion, an average of 1 year
Time it takes subject to get from checked-in to start of scan (in minutes)
Through study completion, an average of 1 year
How long was the scanner unoccupied (in minutes)
Through study completion, an average of 1 year
Number and type of sequences performed
Through study completion, an average of 1 year
Time of scan (in minutes)
Through study completion, an average of 1 year
The subjects in this research study will be recruited by routine medical office exam.The ages for the subjects in this study will range from 18 to 65 years old.The gender distribution for this study will aim for a ratio of 50:50 male to female. There are no enrollment restrictions based upon race or ethnic origin. There are also no additional benefits, risks, advantages, or disadvantages based off of any race or ethnic origin.
Neurological Associates of West Los Angeles
Santa Monica, California, 90403, United States
Sheldon Jordan, MD
Neurological Associates of West Los Angeles
First Submitted
June 12, 2017
First Posted
July 28, 2017
Study Start
June 14, 2016
Actual (reported)Primary Completion
December 30, 2025
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 24, 2023
Record last verified: 2023-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: